Patricia Hare

Patricia Hare


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2021 in Cancer Cell
Verified
Journal Article
Open access
HHHaichuan Hu
Haichuan Hu
ZPZofia Piotrowska
Zofia Piotrowska
PHPatricia Hare
Patricia Hare
HCHuidong Chen
Huidong Chen
HMHillary E. Mulvey
Hillary E. Mulvey
JEJeffrey A. Engelman
Jeffrey A. Engelman
Cancer-associated fibroblasts (CAFs) are highly heterogeneous. With the lack of a comprehensive understanding on CAFs’ functional distinctions, it remains unclear how cancer treatments could be personalized based on CAFs in a patient’s tumor. We have established a living biobank of CAFs derived from biopsies of patients’ non-small lung cancer (NSCLC) that encompasses a broad molecular spectrum of CAFs in clinical NSCLC. By functionally interrogating CAFs heterogeneity using the same therapeutics received by patients, we identify three functional subtypes: 1) robustly protective of cancers and highly expressing HGF and FGF7, 2) moderately protective of cancers and highly expressing FGF7, and 3) those providing minimal protection. These functional differences among CAFs are governed by their intrinsic TGF-β signaling which suppresses HGF and FGF7 expression. This CAF functional classification correlates with patients’ clinical response to targeted therapies and also associates with the tumor immune microenvironment, therefore provides an avenue to guide personalized treatment.

1 November 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
PHPatricia Hare
Patricia Hare
TLTravis J. LaGree
Travis J. LaGree
BBBrandon A. Byrd
Brandon A. Byrd
ADAngela M. DeMarco
Angela M. DeMarco
WMWendy Mok
Wendy Mok
Antibiotic persistence is a phenomenon in which rare cells of a clonal bacterial population can survive antibiotic doses that kill their kin, even though the entire population is genetically susceptible. With antibiotic treatment failure on the rise, there is growing interest in understanding the molecular mechanisms underlying bacterial phenotypic heterogeneity and antibiotic persistence. However, elucidating these rare cell states can be technically challenging. The advent of single-cell techniques has enabled us to observe and quantitatively investigate individual cells in complex, phenotypically heterogeneous populations. In this review, we will discuss current technologies for studying persister phenotypes, including fluorescent tags and biosensors used to elucidate cellular processes; advances in flow cytometry, mass spectrometry, Raman spectroscopy, and microfluidics that contribute high-throughput and high-content information; and next-generation sequencing for powerful insights into genetic and transcriptomic programs. We will further discuss existing knowledge gaps, cutting-edge technologies that can address them, and how advances in single-cell microbiology can potentially improve infectious disease treatment outcomes.

16 July 2021 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
BBBrandon A. Byrd
Brandon A. Byrd
BZBlesing Zenick
Blesing Zenick
MRMaria C. Rocha-Granados
Maria C. Rocha-Granados
HEHanna E. Englander
Hanna E. Englander
PHPatricia Hare
Patricia Hare
WMWendy Mok
Wendy Mok
Bacteria have a repertoire of strategies to overcome antibiotics in clinical use, complicating our ability to treat and cure infectious diseases. In addition to evolving resistance, bacteria within genetically clonal cultures can undergo transient phenotypic changes and tolerate high doses of antibiotics.

5 April 2022 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
PHPatricia Hare
Patricia Hare
HEHanna E. Englander
Hanna E. Englander
WMWendy Mok
Wendy Mok

11 January 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
PHPatricia Hare
Patricia Hare
JGJuliet R. Gonzalez
Juliet R. Gonzalez
RQRyan M. Quelle
Ryan M. Quelle
YWYi I. Wu
Yi I. Wu
WMWendy Mok
Wendy Mok
The ubiquitous opportunistic pathogen Pseudomonas aeruginosa is highly adaptive and refractory to several different classes of antibiotics. However, we found in this study that stationary-phase P. aeruginosa cultures exhibit greater sensitivity to the fluoroquinolone Levofloxacin (Levo) than other bactericidal antibiotics, including an aminoglycoside (Tobramycin) and β-lactam (Aztreonam). To understand the basis of this sensitivity, we conducted time-lapse fluorescence microscopy experiments of cells during Levo treatment. We discovered that stationary-phase P. aeruginosa cells die rapidly during treatment and undergo heterogeneous morphological changes, including explosive lysis, filamentation, and gradual loss of membrane integrity as evidenced by propidium iodide uptake. These morphologies are reminiscent of how the model organism Escherichia coli appears when recovering from fluoroquinolone treatment, a period when activation of the DNA damage-induced SOS response is crucial. Accordingly, we monitored the morphologies and survival of P. aeruginosa Δ recA mutants and found that the SOS response is not involved in P. aeruginosa Levo sensitivity like it is for E. coli . We hypothesized that Levo sensitivity may be due to P. aeruginosa maintaining active metabolism in stationary phase. We determined that stationary-phase P. aeruginosa cells transcribe, maintain reductase activity, and accumulate reactive metabolic species which contribute to Levo-mediated death. By elucidating how P. aeruginosa cells sustain metabolic activity during the stationary phase, we can design strategies to sensitize these persistent subpopulations to Levo and maintain the efficacy of this clinically important fluoroquinolone antibiotic. IMPORTANCE: The bacterial pathogen Pseudomonas aeruginosa is responsible for a variety of chronic human infections. Even in the absence of identifiable resistance mutations, this pathogen can tolerate lethal antibiotic doses through phenotypic strategies like biofilm formation and metabolic quiescence. In this study, we determined that P. aeruginosa maintains greater metabolic activity in the stationary phase compared to the model organism, Escherichia coli , which has traditionally been used to study fluoroquinolone antibiotic tolerance. We demonstrate that hallmarks of E. coli fluoroquinolone tolerance are not conserved in P. aeruginosa , including the timing of cell death and necessity of the SOS DNA damage response for survival. The heightened sensitivity of stationary-phase P. aeruginosa to fluoroquinolones is attributed to maintained transcriptional and reductase activity. Our data suggest that perturbations that suppress transcription and respiration in P. aeruginosa may actually protect the pathogen against this important class of antibiotics.

27 January 2026 in mSphere
Verified
Journal Article
Open access
PHPatricia Hare
Patricia Hare
JGJuliet R. González
Juliet R. González
WMWendy Mok
Wendy Mok
When susceptible bacterial cultures are treated with antibiotics, some cells can survive treatment without heritable resistance, giving rise to susceptible daughter cells in a phenomenon termed antibiotic persistence. Current models of fluoroquinolone (FQ) persistence in stationary-phase cultures posit that post-treatment resuscitation is dependent on double-stranded break (DSB) repair through RecA-mediated homology-directed repair. Previously, we reported that stationary-phase P. aeruginosa does not depend on RecA to persist. In this work, we ask whether P. aeruginosa FQ persisters from stationary-phase cultures suffer DSBs at all. We measured DSB formation in Levofloxacin (LVX)-treated cells recovering from treatment using strains expressing fluorescently labeled DSB-binding protein, Gam. We find that, surprisingly, the majority of P. aeruginosa LVX persisters survive treatment without apparent DSBs. Persisters that have evidence of DSBs take longer until their first division compared to persisters without DSBs. Additionally, the fates of their progenies suggest that persisters may cope with DSBs by repair or damage sequestration. These observations pave the way for mechanistic studies into P. aeruginosa FQ persistence and highlight the need for single-cell tools to track FQ-induced damage. IMPORTANCE: Pseudomonas aeruginosa is an opportunistic pathogen of significant clinical interest. When susceptible cultures of P. aeruginosa are treated with fluoroquinolone (FQ) antibiotics, some cells survive treatment and regrow in a phenomenon termed antibiotic persistence. Studies in Escherichia coli and other bacterial species suggest that FQ persisters survive by repairing DNA double-stranded breaks (DSBs) after antibiotic removal. In this study, we show that most stationary-phase P. aeruginosa survive by avoiding DSBs rather than repairing them.